Skip to content

Automated Western Blotting (Immunoblotting) Services

At Precision, our skilled scientific team provides Western blotting services to support your R&D needs
Western blotting, also known as immunoblotting, is a widely used analytical technique in molecular biology, biochemistry, and immunogenetics. It is primarily used to detect specific proteins in a complex mixture, such as cell lysates or tissue homogenates, by exploiting the specificity of antibody-antigen interactions. At Precision, we utilize an advanced automated platform to ensure accurate, reproducible results, while our expertise in antibody selection guarantees reliable target detection.

Expert immunoblotting services for
targeted protein analysis

Precision for Medicine combines advanced technology with extensive experience to deliver efficient, accurate Western blotting solutions tailored to your unique project requirements. Precision's tools for western blotting offer a wide range of advantages for reliable protein analysis, including:

  • Automated Western blot protocol for improved precision and reproducibility
  • Optimized reagents and validated antibodies for consistent results
  • Quantitative Western blot data for in-depth protein characterization
  • Low sample input requirements to maximize data generation
  • Multiplexing capabilities for simultaneous target detection and analysis
  • GxP-compliant software for regulatory compliance
  • Compatibility with diverse sample types for flexible research applications
proteins-jess

Precision offers protein analysis and target validation using the Jess automated system

By automating the labor-intensive process of Western blotting (immunoblotting), we can precisely detect and quantify specific proteins, enabling comprehensive protein profiling.

Precision for Medicine harnesses the power of Jess™ and other advanced platforms to support drug development and diagnostics, offering precise protein quantification and validation to facilitate personalized medicine and targeted therapy research.

Integrate western blotting with additional assays

Precision understands the value of comprehensive protein research, offering a range of complementary techniques to enhance your Western blotting (immunoblotting) data:

Combine Western blotting (immunoblotting) with IHC and multiplex immunofluorescence for detailed tissue biomarker analysis.

Employ liquid biopsies for serial assessment of pharmacodynamic biomarkers when tissue samples are limited.

Utilize flow cytometry for in-depth analysis of the immune system in both tumor and blood samples.

Apply FISH or ISH techniques to detect chromosomal abnormalities or mRNA expression in the same tissue samples used for Western blotting (immunoblotting).

Explore related services

  • Explore
    Cytokine

    Meso Scale Discovery (MSD)

    Measuring a range of analytes in complex sample matrices consistently and at high sensitivity, with applications including ADA, NAb, TAb, and PK assays.
    Explore
  • Explore

    Olink Proteomics

    High-multiplex quantification of protein biomarkers with minimal clinical sample volume and exceptional sensitivity and specificity.
    Explore
  • Explore

    Luminex®

    Luminex is useful when multiplexed measurements at high sensitivity, even in complex matrices, are needed. We generally utilize the Luminex platform in early phase studies profiling cytokines and other analytes.
    Explore

Explore the Precision blog

Read our blog to gain more insights and discover work that Precision has supported.

Read: Protein Assays: Choosing the Most Effective Method for Biopharmaceutical Development Protein Assays: Choosing the Most Effective Method for Biopharmaceutical Development

Translational Research - Lab Services - Biomarkers

Protein Assays: Choosing the Most Effective Method for Biopharmaceutical Development

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778889, hs_child_table_id=0, hs_updated_at=1714461111815, hs_published_at=1738195925606, description=Travis Harrison, PhD, is Vice President of Diagnostic Development at Precision for Medicine. He brings more than 20 years of bioanalytical assay experience to the Precision team with expertise in ligand-binding and cell-based assays.  Travis has experience supporting clinical and nonclinical studies for a broad range of indications, with an emphasis on diagnostic assays to evaluate immune responses to gene therapies., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Travis%20Harrison.webp',altText='Travis Harrison',fileId=165893006481}, linkedin=https://www.linkedin.com/in/travis-harrison-phd-6108852/, hs_name=, hs_path=, lastname=Harrison, hs_initial_published_at=1716212769184, hs_created_at=1709645745120, hs_is_edited=false, hs_deleted_at=0, name=Travis, job=, slug=travis-harrison, email=, hs_updated_by_user_id=51739740}, second={hs_id=159488778875, hs_child_table_id=0, hs_updated_at=1716454216458, hs_published_at=1738195925606, description=Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Deb%20Phippard.webp',altText='Deb Phippard',fileId=165892372605}, linkedin=https://www.linkedin.com/in/deb-phippard-103b54, team=[{id=163072475007, name='Precision for Medicine Leadership'}], hs_name=, hs_path=, lastname=Phippard, PhD, hs_initial_published_at=1716212769184, hs_created_at=1709645745106, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job= Chief Scientific Officer, slug=deborah-phippard, email=, hs_updated_by_user_id=51739740}, third={}})
  • Travis H. avatar

    Travis H.

  • Deborah P. avatar

    Deborah P.

Discover